Presynaptic D1 heteroreceptors and mGlu autoreceptors act at individual cortical release sites to modify glutamate release
Autor: | Gordon W. Arbuthnott, Marianela Garcia-Munoz, Takuya Hikima |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
medicine.medical_specialty Neuroscience(all) Dopamine Clinical Neurology Presynaptic Terminals Stimulation Biology Receptors Metabotropic Glutamate Heteroreceptor Synaptic vesicle 03 medical and health sciences chemistry.chemical_compound Protein kinase A 0302 clinical medicine Cultures Dopamine receptor D2 Internal medicine medicine Animals Humans Molecular Biology Cells Cultured Autoreceptors Cerebral Cortex Forskolin Receptors Dopamine D1 General Neuroscience Glutamic acid Endocytosis Mice Inbred C57BL HEK293 Cells 030104 developmental biology Metabotropic receptor Endocrinology chemistry Biophysics Autoreceptor Synaptic Vesicles Neurology (clinical) Glutamate 030217 neurology & neurosurgery Developmental Biology |
Zdroj: | Brain Research. 1639:74-87 |
ISSN: | 0006-8993 |
Popis: | The aim of this work was to study release of glutamic acid (GLU) from one-axon terminal or bouton at-a-time using cortical neurons grown in vitro to study the effect of presynaptic auto- and heteroreceptor stimulation. Neurons were infected with release reporters SypHx2 or iGluSnFR at 7 or 3 days-in-vitro (DIV) respectively. At 13–15 DIV single synaptic boutons were identified from images obtained from a confocal scanning microscope before and after field electrical stimulation. We further stimulated release by raising intracellular levels of cAMP with forskolin (10µM). Forskolin-mediated effects were dependent on protein kinase A (PKA) and did not result from an increase in endocytosis, but rather from an increase in the size of the vesicle readily releasable pool. Once iGluSnFR was confirmed as more sensitive than SypHx2, it was used to study the participation of presynaptic auto- and heteroreceptors on GLU release. Although most receptor agonizts (carbamylcholine, nicotine, dopamine D2, BDNF) did not affect electrically stimulated GLU release, a significant increase was observed in the presence of metabotropic D1/D5 heteroreceptor agonist (SKF38393 10µM) that was reversed by PKA inhibitors. Interestingly, stimulation of group II metabotropic mGLU2/3 autoreceptors (LY379268 50nM) induced a decrease in GLU release that was reversed by the specific mGLU2/3 receptor antagonist (LY341495 1µM) and also by PKA inhibitors (KT5720 200nM and PKI14-22 400nM). These changes in release probability at individual release sites suggest another level of control of the distribution of transmitter substances in cortical tissue. |
Databáze: | OpenAIRE |
Externí odkaz: |